LIU, Yanxin; DONG, Changjiang; HE, Xucheng; SHU, Yamin; WU, Pan; ZOU, Jian. Post-Marketing Safety of Vemurafenib: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System. Journal of Pharmacy & Pharmaceutical Sciences, [S. l.], v. 25, p. 377–390, 2022. DOI: 10.18433/jpps33020. Disponível em: https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/33020. Acesso em: 23 nov. 2024.